raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:502423

Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome

Synonyms: Mitochondrial myopathy-cerebellar atrophy-pigmentary retinopathy syndrome

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant
Age of onset
Adult, Infancy
Status
active

A rare mitochondrial myopathy characterized by motor developmental delay (in infancy), growth impairment and mostly proximal muscle weakness caused by a muscular dystrophy. Muscle biopsy presents myopathic abnormalities and decreased mtDNA content. Electromyography (EMG) shows a myopathic process and serum creatine kinase is increased. The disease is also characterized by early onset non-progressive cerebellar atrophy (particularly cerebellar vermis and hemispheres), corticospinal tract dysfunction, and global or partial cerebral atrophy on brain MRI. Additionally, some patients presented with cognitive deficiencies, skeletal abnormalities, tremors, and retinopathy.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enMitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndromeMitochondrial myopathy-cerebellar atrophy-pigmentary retinopathy syndrome
frSyndrome de myopathie mitochondriale-ataxie cérébelleuse-rétinopathie pigmentaireSyndrome de myopathie mitochondriale-atrophie cérébelleuse-rétinopathie pigmentaire
deMitochondriale Myopathie-zerebelläre Ataxie-Pigmentretinopathie-SyndromMitochondriale Myopathie-zerebelläre Atrophie-Pigmentretinopathie-Syndrom
esSíndrome de miopatía mitocondrial-ataxia cerebelosa-retinopatía pigmentariaSíndrome de miopatía mitocondrial-atrofia cerebelosa-retinopatía pigmentaria
itSindrome miopatia mitocondriale-atassia cerebellare-retinite pigmentosa
nlMitochondriale myopathie - cerebellaire ataxie - pigmentretinopathie-syndroomMitochondriale myopathie - cerebellaire atrofie - pigmentretinopathie-syndroom
ptSíndrome de miopatia mitocondrial-ataxia cerebelosa-retinopatia pigmentosaSíndrome de miopatia mitocondrial-atrofia cerebelosa-retinopatia pigmentosa
plZespół miopatii mitochondrialnej, ataksji móżdżkowej i retinopatii barwnikowej= en
csMitochondriální syndrom zahrnující myopatii, mozečkovou ataxii a pigmentovou retinopatiiMitochondrial myopathy-cerebellar atrophy-pigmentary retinopathy syndrome · Syndrom zahrnující mitochondriální myopatii, cerebelární atrofii a pigmentovou retinopatii
ukСиндром мітохондріальної міопатії-мозочкової атаксії-пігментної ретинопатіїСиндром мітохондріальної міопатії-мозочкової атрофії-пігментної ретинопатії
zh线粒体肌病-小脑共济失调-色素性视网膜病变综合征线粒体肌病-小脑萎缩-色素性视网膜病变综合征
trMitokondriyal miyopati-serebellar ataksi-pigmenter retinopati sendromuMitokondriyal miyopati-serebellar atrofi-pigmenter retinopati sendromu

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM617675Evalidated
ICD-10G71.3NTBTattributedvalidated
ICD-118C73.YNTBTattributedvalidated
MONDO0044714Evalidated
UMLSC4540096Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (5):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
MSTO1Disease-causing germline mutation(s) inAssessedHGNC:29678ENSG000001254596176191q22misato mitochondrial distribution and morphology regulator 128544275[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families9 casesWorldwideCase(s)Validated28544275[PMID]_28554942[PMID]_29339779[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_28544275[PMID]_28554942[PMID]_29339779[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

47 annotations · validated 2018-12-03
HPOTerm (as annotated by Orphanet)Diagnostic
Frequent (79-30%)
HP:0100887Abnormality of globe size
HP:0000739Anxiety
HP:0001321Cerebellar hypoplasia
HP:0002750Delayed skeletal maturation
HP:0000750Delayed speech and language development
HP:0000716Depression
HP:0002075Dysdiadochokinesis
HP:0001310Dysmetria
HP:0003458EMG: myopathic abnormalities
HP:0001288Gait disturbance
HP:0001290Generalized hypotonia
HP:0002761Generalized joint hypermobility
HP:0003391Gowers sign
HP:0001510Growth delay
HP:0000365Hearing impairment
HP:0000218High palate
HP:0030890Hyperintensity of cerebral white matter on MRI
HP:0000836Hyperthyroidism
HP:0001265Hyporeflexia
HP:0000601Hypotelorism
HP:0000870Increased circulating prolactin concentration
HP:0012240Increased intramyocellular lipid droplets
HP:0009051Increased muscle glycogen content
HP:0003557Increased variability in muscle fiber diameter
HP:0001256Intellectual disability, mild
HP:0012032Lipoma
HP:0000276Long face
HP:0000347Micrognathia
HP:0008180Mildly elevated creatine kinase
HP:0003737Mitochondrial myopathyDiagnostic criterion
HP:0001270Motor delay
HP:0003326Myalgia
HP:0000767Pectus excavatum
HP:0001761Pes cavus
HP:0000786Primary amenorrhea
HP:0002073Progressive cerebellar ataxiaDiagnostic criterion
HP:0003701Proximal muscle weakness
HP:0002650Scoliosis
HP:0004322Short stature
HP:0003474Somatic sensory dysfunction
HP:0100874Thick hair
HP:0001337Tremor
HP:0030319Weakness of facial musculature
Occasional (29-5%)
HP:0000729Autistic behavior
HP:0100753Schizophrenia
Very rare (<4-1%)
HP:0000543Optic disc pallor
HP:0000580Pigmentary retinopathyDiagnostic criterion

Annotation source: 28544275[PMID]_28554942[PMID]

7

Sources for this card